Multiple Sclerosis Ireland

Lobbying Organisation Multiple Sclerosis Ireland

Date published 08 Sep, 2022

Relevant Matter Matters involving public funds

Public Policy Area Health

Period 1 May, 2022 to 31 Aug, 2022

Specific Details The Multiple Sclerosis Society of Ireland invited a number of Oireachtas members to visit our National MS Care Centre and to request their support for the ask for additional funding in Budget 2023

Intended results Ask regarding the National MS Care Centre of the Pre-Budget Submission met in Budget 2023

Name of person primarily responsible for lobbying on this activity Alison Cotter

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Email (1)

Personalised email sent to a number of Oireachtas members to visit our National MS Care Centre and to request their support for the ask for additional funding in Budget 2023

Letter (1)

Personalised letter sent to a number of Oireachtas members to visit our National MS Care Centre and to request their support for the ask for additional funding in Budget 2023

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Ivana Bacik TD (Dáil Éireann, the Oireachtas)

Jim O'Callaghan TD (Dáil Éireann, the Oireachtas)

Chris Andrews TD (Dáil Éireann, the Oireachtas)

Eamon Ryan TD (Dáil Éireann, the Oireachtas)